Which assessment finding would a health care provider recognize as evidence of a paraneoplastic syndrome in an individual receiving radiation therapy for metastatic cancer?
Answers from top 10 papers
More filters
| Papers (10) | Insight |
|---|---|
65 Citations | Recognition of paraneoplastic syndromes is important, as it may lead to an early diagnosis of cancer. |
| There was also uptake by a sacral tumour, suggesting a diagnosis of paraneoplastic syndrome. | |
36 Citations | Recognition of this paraneoplastic syndrome may forewarn the physician of an underlying breast malignancy. |
| An elevated tumor marker in a patient with a presumed paraneoplastic neurologic disorder should suffice as evidence of an occult neoplasm, and guide definitive treatment. | |
4 Citations | Early recognition can lead to effective treatment of a paraneoplastic syndrome and a potential cure of the underlying cancer. |
48 Citations | Some syndromes are associated with serum markers that are readily detectable and demonstration of these putative markers within prostate cancer tissue at an individual level would firmly link the paraneoplastic syndrome with its underlying prostatic malignancy. |
Open access•Journal Article 15 Sep 1983-La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris 3 Citations | It is pointed out that a paraneoplastic syndrome should always lead to a careful investigation for cancer. |
Open access•Journal Article 9 Citations | A paraneoplastic syndrome may be the first sign of a malignancy so its recognition may be critical for early cancer detection. |
| Learning to recognize paraneoplastic neuromuscular disorders, the associated antibodies and their implications, and the appropriate screening modalities can, in some cases, lead to an earlier diagnosis of cancer. | |
| The initial evaluation of the patient with known or suspected lung cancer should include an assessment of symptoms, signs, and laboratory test results in a standardized manner as a screen for identifying those patients with paraneoplastic syndromes and a higher likelihood of metastatic disease. |
Related Questions
What are the psicological tests used to evaluate psilocybin assisted psychotherapy in cancer patients?4 answersPsilocybin-assisted psychotherapy for cancer patients has been evaluated using various psychological tests. The studies have used measures such as the Montgomery Asberg Depression Rating Scale (MADRS) and the Hamilton Depression Rating Scale (HAM-A) to assess depression and anxiety severity. Qualitative methods, such as semistructured interviews and interpretative phenomenological analysis, have also been employed to understand patient experiences and psychological mechanisms of action. Additionally, self, community, and clinician reports have been used as subjective outcome measures to evaluate the effects of psilocybin on psychological distress. The studies have focused on assessing the impact of psilocybin on symptoms of anxiety, depression, and existential concerns, as well as attitudes toward disease progression, death, and spirituality.
Infertility diagnosis and radiation risks assessment?4 answersHysterosalpingography (HSG) is a commonly used diagnostic method for evaluating female infertility. It involves exposing patients to ionizing radiation, which raises concerns about radiation risks. Several studies have assessed the radiation dose and associated risks of HSG procedures. The mean entrance surface dose (ESD) ranged from 3.60 to 34.24 mGy, with corresponding effective doses ranging from 1.24 to 2.53 mSv. The estimated risks for cancer and hereditary effects were 24 x 10^-6 and 3.4 x 10^-6, respectively. However, these risks were considered comparable to natural incidence rates and were generally within international standards. CT-VHSG, a computerized tomography-based technique, was found to have high diagnostic performance and a lower radiation dose compared to conventional HSG. Overall, while radiation risks should be considered, HSG procedures can be considered safe when performed with optimized protocols and adherence to radiation protection guidelines.
What are the anxiety levels of cancer patients when being confronted with treatment options?\?5 answersAnxiety levels of cancer patients when being confronted with treatment options vary depending on the stage of treatment and specific procedures. Patients who appeared for tumor board decision showed the highest state-anxiety levels, followed by patients undergoing surgery. Patients already undergoing chemotherapy had lower state-anxiety levels than other patients. Patients undergoing chemotherapy also showed lower anxiety levels relating to many procedures of breast cancer treatment. In more advanced stages of cancer, patients were more likely to have higher levels of anxiety. It is important to provide psychological support to patients in the early stage of cancer detection and when metastases form. A strong patient-healthcare provider relationship after diagnosis may help reduce distress among patients with higher levels of medical mistrust.
What are the most common functional assessments used for cancer patients that receiving chemotherapy?3 answersThe most common functional assessments used for cancer patients receiving chemotherapy include the Nutrition Risk Screening (NRS) 2002, the Functional Assessment of Anorexia/Cachexia Therapy (FAACT), and the Eastern Cooperative Oncology Group (ECOG) criteria. The NRS 2002 is used to assess the risk of malnutrition in cancer patients undergoing chemotherapy. The FAACT is used to determine the functional status of cancer patients, specifically in relation to anorexia and cachexia. The ECOG criteria are widely used to evaluate a patient's performance status, which is an important factor in determining treatment options for cancer patients. These assessments help healthcare professionals understand the nutritional and functional status of cancer patients undergoing chemotherapy, allowing for better care and treatment decisions.
Why pain assessment is important in cancer patient?4 answersPain assessment is important in cancer patients because it allows for proper recognition and understanding of the type and severity of pain experienced, which is crucial for effective pain management. Cancer pain can be complex and heterogeneous, with multiple contributing factors, and can have a significant impact on various aspects of a patient's life. By assessing pain, healthcare professionals can tailor treatment strategies to target specific pain mechanisms, such as nociceptive, neuropathic, nociplastic, or mixed pain, leading to better pain control. Additionally, pain assessment helps in identifying the underlying cause of pain, which can guide the selection of appropriate pharmacological and non-pharmacological interventions. Understanding the patient's pain experience also allows for a holistic approach to care, addressing not only the physical aspects but also the psychological, social, and spiritual dimensions of pain. Overall, pain assessment plays a crucial role in improving the quality of life for cancer patients by facilitating personalized and multimodal pain management.
Assessments for patient Cushing's syndrome?3 answersAssessments for Cushing's syndrome include various screening tests and diagnostic procedures. Initial workup should begin with excluding local and systemic corticosteroid use. First-line screening tests include the 1-mg dexamethasone suppression test, 24-hour urinary free cortisol excretion, and late-night salivary cortisol measurement. In addition, scalp-hair cortisol/cortisone analysis can help assess long-term glucocorticoid exposure and detect transient periods of hypercortisolism. Once endogenous Cushing syndrome is established, measurement of plasma ACTH concentrations can differentiate between ACTH-dependent and ACTH-independent causes. Further assessment may involve different imaging modalities and dynamic biochemical testing, such as bilateral inferior petrosal sinus sampling, to pinpoint the cause of Cushing's syndrome. Ophthalmologic evaluation, including Enhanced-Depth Imaging (EDI)-Optical Coherence Tomography (OCT), can detect chorioretinal abnormalities in patients with Cushing syndrome. The drawing test can also be used to assess perceptions of patients about their disease and its relation to illness perceptions, quality of life, and clinical disease severity. Communication between physicians and patients is crucial for providing sufficient information and improving health-related quality of life during recovery.